Aspirin, Dietary Resistant Starch, and Other Approaches to Reducing Lynch Syndrome Cancer Risk

Learn about various strategies to reduce cancer risk for individuals with Lynch syndrome in this 14-minute talk by Dr. Matt Yurgelun from Dana-Farber Cancer Institute. Explore the potential benefits of aspirin and dietary resistant starch as preventive measures, and gain insights from the CAPP2 study findings. Discover practical approaches that may help lower cancer risk for those with Lynch syndrome through this informative presentation that covers multiple risk reduction strategies.